Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 5,019,000 | 4,926,000 | 4,563,000 | 5,111,000 | 4,658,000 |
| Cost of Goods | 1,094,000 | 1,113,000 | 1,100,000 | 1,282,000 | 1,092,000 |
| Gross Profit | 3,925,000 | 3,813,000 | 3,463,000 | 3,829,000 | 3,566,000 |
| Operating Expenses | 2,965,000 | 2,298,000 | 2,112,000 | 2,294,000 | 2,195,000 |
| Operating Income | 960,000 | 1,515,000 | 1,351,000 | 1,535,000 | 1,371,000 |
| Interest Expense | 148,000 | 73,000 | 70,000 | 74,000 | 75,000 |
| Other Income | -125,000 | -9,000 | 5,000 | -22,000 | -10,000 |
| Pre-tax Income | 687,000 | 1,433,000 | 1,286,000 | 1,439,000 | 1,286,000 |
| Income Tax | 181,000 | 335,000 | 306,000 | 311,000 | 322,000 |
| Net Income Continuous | 506,000 | 1,098,000 | 980,000 | 1,128,000 | 964,000 |
| Net Income | $506,000 | $1,098,000 | $980,000 | $1,128,000 | $964,000 |
| EPS Basic Total Ops | 0.03 | 0.07 | 0.06 | 0.08 | 0.06 |
| EPS Basic Continuous Ops | 0.03 | 0.07 | 0.06 | 0.08 | 0.06 |
| EPS Diluted Total Ops | 0.03 | 0.07 | 0.06 | 0.07 | 0.06 |
| EPS Diluted Continuous Ops | 0.03 | 0.07 | 0.06 | 0.07 | 0.06 |
| EBITDA(a) | $1,027,000 | $1,708,000 | $1,555,000 | $1,713,000 | $1,595,000 |